SHAREHOLDERS’ DEFICIT

6 Months Ended

Mar. 31, 2022

Equity [Abstract]

SHAREHOLDERS’ DEFICIT

NOTE 9. SHAREHOLDERS’ DEFICIT

Preferred Stock

As of March 31, 2022, we were authorized to issue 10,000,000 shares of preferred stock with a par value of $0.0001.

No shares of preferred stock were issued and outstanding during the three months ended March 31, 2022.

No series of preferred stock or rights for preferred stock had been designated on March 31, 2022.

Common Stock

As of March 31, 2022, we were authorized to issue 1,990,000,000 shares of common stock with a par value of $0.0001.

As of September 15, 2020, the effective date of the reverse recapitalization, 619,085 shares of common stock were issued and outstanding in our predecessor company with a total par value of $62 and negative balance of additional paid in capital totaling $(15,550).

As of September 30, 2021, 619,085 shares of common stock were issued and outstanding.

No shares of common stock were issued during the six months ended March 31, 2022.

Effective December 29, 2020, we completed a 2,000:1 reverse stock split. All numbers of our common shares disclosed as issued and outstanding in this Form 10Q have been retrospectively restated to reflect the impact of the reverse split.

As of March 31, 2022, 619,085 shares of common stock were issued and outstanding.

Warrants

No warrants were issued or outstanding during the three months ended March 31, 2022.

Stock Options

We currently have no stock option plan.

No stock options were issued or outstanding during the three months ended March 31, 2022.